Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abigail T Berman

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
International Journal of Radiation Oncology, Biology, Physics|October 27, 2019
Early Tumor and Nodal Response in Patients with Locally Advanced Non-Small Cell Lung Carcinoma Predict for Oncologic Outcomes in Patients Treated with Concurrent Proton Therapy and ChemotherapyAmardeep S Grewal, Eun Jeong Min, Qi Long, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2023
Prospective Feasibility and Phase 1/2 Trial of Preoperative Proton Beam Therapy With Concurrent Chemotherapy for Resectable Stage IIIA or Superior Sulcus Non-Small Cell Lung CancerCharles B Simone, Nikhil Yegya-Raman, Shwetha Manjunath, et al.
Journal of Surgical Oncology|June 27, 2020
Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicityBrian C Baumann, Karen De Amorim Bernstein, Thomas F DeLaney, et al.
British Journal of Cancer|October 16, 2018
A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumoursAmit Maity, Rosemarie Mick, Alexander C Huang, et al.
Clinical Lung Cancer|April 19, 2023
Utilization and Factors Precluding Receipt of Checkpoint Inhibitor Consolidation for Stage III NSCLC in a Large US Academic Health SystemNikhil Yegya-Raman, Cole Friedes, Lova Sun, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2023
Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung CancerNikhil Yegya-Raman, Abigail T Berman, Christine A Ciunci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2020
Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non-Small Cell Lung CancerCharu Aggarwal, Jeffrey C Thompson, Austin L Chien, et al.
JAMA Oncology|October 17, 2018
Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung CancerCharu Aggarwal, Jeffrey C Thompson, Taylor A Black, et al.
Clinical and Translational Radiation Oncology|January 24, 2023
Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancerNikhil Yegya-Raman, Timothy P Kegelman, Sang Ho Lee, et al.
Medical Physics|July 14, 2022
Combining natural and artificial intelligence for robust automatic anatomy segmentation: Application in neck and thorax auto-contouringJayaram K Udupa, Tiange Liu, Chao Jin, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
International Journal of Radiation Oncology, Biology, Physics|October 27, 2019
Early Tumor and Nodal Response in Patients with Locally Advanced Non-Small Cell Lung Carcinoma Predict for Oncologic Outcomes in Patients Treated with Concurrent Proton Therapy and ChemotherapyAmardeep S Grewal, Eun Jeong Min, Qi Long, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2023
Prospective Feasibility and Phase 1/2 Trial of Preoperative Proton Beam Therapy With Concurrent Chemotherapy for Resectable Stage IIIA or Superior Sulcus Non-Small Cell Lung CancerCharles B Simone, Nikhil Yegya-Raman, Shwetha Manjunath, et al.
Journal of Surgical Oncology|June 27, 2020
Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicityBrian C Baumann, Karen De Amorim Bernstein, Thomas F DeLaney, et al.
British Journal of Cancer|October 16, 2018
A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumoursAmit Maity, Rosemarie Mick, Alexander C Huang, et al.
Clinical Lung Cancer|April 19, 2023
Utilization and Factors Precluding Receipt of Checkpoint Inhibitor Consolidation for Stage III NSCLC in a Large US Academic Health SystemNikhil Yegya-Raman, Cole Friedes, Lova Sun, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2023
Phase 2 Trial of Consolidation Pembrolizumab After Proton Reirradiation for Thoracic Recurrences of Non-Small Cell Lung CancerNikhil Yegya-Raman, Abigail T Berman, Christine A Ciunci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2020
Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non-Small Cell Lung CancerCharu Aggarwal, Jeffrey C Thompson, Austin L Chien, et al.
JAMA Oncology|October 17, 2018
Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung CancerCharu Aggarwal, Jeffrey C Thompson, Taylor A Black, et al.
Clinical and Translational Radiation Oncology|January 24, 2023
Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancerNikhil Yegya-Raman, Timothy P Kegelman, Sang Ho Lee, et al.
Medical Physics|July 14, 2022
Combining natural and artificial intelligence for robust automatic anatomy segmentation: Application in neck and thorax auto-contouringJayaram K Udupa, Tiange Liu, Chao Jin, et al.
Pageof 8